Twitter universal website tag code Twitter website tag code

[Skip to content]

Private hospital continually investing in advanced diagnostic and treatment technologies
Search our Site

Medical Oncologist Philip Savage, Private Clinic Treatment, Self Pay Patients

Dedicated GP referral service

Call Cromwell Direct to make a referral on

+44 (0)800 783 9229

More about Cromwell Direct

Make a referral

Refer a patient to us by telephone, fax or email

How to refer

Make an appointment

8am-8pm Monday to Friday
8am-2pm Saturday
Call our Contact Centre on

+44 (0)20 7460 5700

Contact Us

Dr Philip Savage, Consultant Medical Oncologist

Specialist Details
Full name

Dr Philip Savage




Consultant Medical Oncologist


Oncology - medical

Site specialisation

Urological Cancer

Site specialisation 2

Testicular Cancer

Clinical interests

Urological Cancers, Testicular Cancer

Background Information

Dr Philip Savage trained in Medicine in Bristol and in Medical Oncology at the Royal Marsden and Imperial Hospitals. He was a Consultant at Charing Cross Hospital for 10 years, where he was clinical lead for testicular cancer, urology oncology, chemotherapy and acute oncology. Following a career sabbatical with the BCCA in Canada, he returned to the UK practice now working in Brighton. He has a strong research interest and has over 150 medical and scientific publications. Alongside this he has extensive experience in clinical care of patients with urological malignancies.

Languages spoken


Regular Cromwell clinics


Clinic days

Mon: Tue: Wed: Thurs: Fri: amSat: am

Appointments telephone number

020 3311 1419

Additional Career Information
Year qualified



Royal College of Physicians 
Association of Cancer Physicians

NHS hospitals

Brighton and Sussex


Brighton and Sussex University Hospitals NHS Trust

Research interests

Immunotherapy, gene therapy, cancer genetics, health economics

Key published papers

Savage, P. Chemotherapy Curable Malignancies and their Cancer Stem Cells. A Biological and Clinical Review and Hypothesis. BMC Cancer. 2016 21;16(1):906. 
Savage P. Economic and Logistic Challenges of Modern Oncology Healthcare. Clin Oncol (R Coll Radiol). 2017 29(9):547-549 
Savage, P., Cowburn, P., Clayton A., et al. Anti-viral Cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice. Int J Cancer 2002;98:561-566 
Savage P, Cooke R, O?Nions J, et al. The effects of single agent and combination chemotherapy for gestational trophoblastic tumours on risks of second malignancy and early menopause. J Clin Oncol. 2015;33:472-478 
Mous R, Savage P, Remmerswaal EB, et al. Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes. Leukemia. 2006;20:1096-1102. 


Media coverage

Our health professionals regularly contribute to hospital publications, as well as national newspaper articles and television coverage.